Cited by 125Muscle Physiology and DisordersTGF-β signaling in diseasesNutrition and Health in Aging

Myostatin: more than just a regulator of muscle mass

Argilés, Josep M., Orpí, Marcel, Busquets, Sílvia, López-Soriano, Francisco J.·2012·Drug Discovery Today

Abstract

The presence of sufficient skeletal muscle mass is of paramount importance for body function and the myostatin cascade is known to inhibit muscle growth in mammals. In addition, myostatin seems to have an important role in the cross-talk between skeletal muscle and adipose tissue and is involved in insulin sensitivity. In this article we highlight the latest developments related to the myostatin system, emphasizing therapeutic implications for wasting diseases and also the involvement of the system in other organs, in addition to skeletal muscle, such as heart or adipose tissue. Moreover, we highlight the possible role of the myostatin system in the cross-talk between skeletal muscle and adipose tissue, an important aspect that deserves consideration in wasting diseases.

Integrity signals

Registry

Crossref · 10.1016/j.drudis.2012.02.001

Cites

95 of 95 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

3 of the 98 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Argilés, J. M., Orpí, M., Busquets, S., & López-Soriano, F. J.
Affiliations
  • Institut de Biomedicina de la Universitat de Barcelona (ES)
  • Universitat de Barcelona (ES)
Venue
Drug Discovery Today
Publisher
Elsevier BV
Published
2012-07
Volume
17
Issue
13-14
Pages
702-709
ISSN
1359-6446 (ISSN-L)
OpenAlex
W1975544443
Cited by
125
References
98
Citations by year
2026: 5 · 2025: 4 · 2024: 6 · 2023: 4 · 2022: 13 · 2021: 7 · 2020: 8 · 2019: 11 · 2018: 14 · 2017: 13 · 2016: 13 · 2015: 9 · 2014: 10 · 2013: 8
FWCI
0.79
Type
journal article
Language
en
Open access
closed
Locations
  • Drug Discovery Today (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
  • Health Sciences › Medicine › Physiology › Nutrition and Health in Aging
Keywords
myostatin, skeletal muscle mass, insulin sensitivity, wasting disease, muscle atrophy, heart, adipose tissue, therapeutic target
MeSH terms
Adipose Tissue, Animals, Cachexia, Exercise Therapy, Glucocorticoids, Humans, Insulin Resistance, Organ Size, Muscle, Skeletal, Wasting Syndrome, Myostatin

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review